The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity-Reference-Cited by-同舟云学术

The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity

Published:2023-09-19 Issue: Volume: Page:
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Suleiman Muna,Al Najjar Afnan,Zakaria Zain Z.,Ahmed Rashid,Yalcin Huseyin C.,Korashy Hesham M.,Uddin Shahab,Riaz Sadaf,Abdulrahman Nabeel,Mraiche Fatima^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12265-023-10431-4.pdf

Reference110 articles.

1. Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829–30.

2. Curigliano G, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309–25.

3. Teske A, et al. Cardio-oncology: an overview on outpatient management and future developments. Neth Hear J. 2018;26(11):521–32.

4. Wickramasinghe CD, et al. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity. Future Oncol. 2016;12(6):855–70.

5. Han X, Zhou Y, Liu W. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy. NPJ Precis Oncol. 2017;1(1):1–11.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights;Trends in Cancer;2024-08